Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Another perspective

Hi

I believe S&L are limited to less then 10% of the total outstanding shares. Which would be around 39 million, otherwise there would be additional filing requirements that would make this public knowledge. If some clearly knows different it would be nice to hear.

I thank Ron for his consideration to provide us with his last input from the hearing. If he knows anything more that he can share and shed more light on the hearing that would also be great.

Share
New Message
Please login to post a reply